These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3307075)

  • 1. [Lines of transformed murine thymus cells. I. Production of the lines].
    Shichkin VP; Iarilin AA; Terekhov OP
    Tsitologiia; 1987 Jun; 29(6):689-94. PubMed ID: 3307075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lines of transformed mouse thymus cells. II. Cell morphology, karyology, ultrastructure and growth in vitro and in vivo].
    Shichkin VP; Iarilin AA; Gudima GO; Rodova MA
    Tsitologiia; 1987 Sep; 29(9):1036-40. PubMed ID: 3501622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
    Minkowski MD; Castellazzi M; Buttin G
    J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice.
    Schols D; Vandekerckhove B; Jones D; Roncarolo MG
    J Immunol; 1994 Mar; 152(5):2198-206. PubMed ID: 8133034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells.
    Friend SL; Hosier S; Nelson A; Foxworthe D; Williams DE; Farr A
    Exp Hematol; 1994 Mar; 22(3):321-8. PubMed ID: 8112430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells.
    Dieli F; Asherson GL; Romano GC; Sireci G; Gervasi F; Salerno A
    J Immunol; 1994 Mar; 152(6):2698-704. PubMed ID: 8144876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
    Zier KS; Salvadori S; Cronin KC; Gansbacher B
    Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ; Thompson JS; Jennings CD; Brown SA
    Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary transfection as a mechanism for transformation of host cells by human tumor cells implanted in nude mice.
    Gupta V; Rajaraman S; Gadson P; Costanzi JJ
    Cancer Res; 1987 Oct; 47(19):5194-201. PubMed ID: 3621205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
    Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
    J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD fetal thymus organ culture: an in vitro model for the development of T cells involved in IDDM.
    Wilson SS; DeLuca D
    J Autoimmun; 1997 Oct; 10(5):461-72. PubMed ID: 9376074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts.
    Peters SO; Kittler EL; Ramshaw HS; Quesenberry PJ
    Exp Hematol; 1995 May; 23(5):461-9. PubMed ID: 7536685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.